Mednax Ev To Operating Cash Flow from 2010 to 2024

MD Stock  USD 14.96  0.21  1.42%   
Mednax's EV To Operating Cash Flow is decreasing over the years with slightly volatile fluctuation. EV To Operating Cash Flow is expected to dwindle to 9.75. EV To Operating Cash Flow is a valuation metric comparing Mednax's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. View All Fundamentals
 
EV To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
10.26584827
Current Value
9.75
Quarterly Volatility
11.41877782
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.6 M, Interest Expense of 24.4 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.37, Dividend Yield of 0.0 or PTB Ratio of 0.87. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
Check out the analysis of Mednax Correlation against competitors.

Latest Mednax's Ev To Operating Cash Flow Growth Pattern

Below is the plot of the Ev To Operating Cash Flow of Mednax Inc over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Mednax's EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Ev To Operating Cash Flow10 Years Trend
Slightly volatile
   Ev To Operating Cash Flow   
       Timeline  

Mednax Ev To Operating Cash Flow Regression Statistics

Arithmetic Mean18.04
Geometric Mean15.93
Coefficient Of Variation63.31
Mean Deviation7.55
Median13.28
Standard Deviation11.42
Sample Variance130.39
Range40.5482
R-Value(0.32)
Mean Square Error125.85
R-Squared0.10
Significance0.24
Slope(0.82)
Total Sum of Squares1,825

Mednax Ev To Operating Cash Flow History

2024 9.75
2023 10.27
2022 11.88
2021 38.92
2020 13.33
2019 11.62
2018 17.05

About Mednax Financial Statements

Mednax stakeholders use historical fundamental indicators, such as Mednax's Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Operating Cash Flow 10.27  9.75 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Mednax Correlation against competitors.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.11)
Earnings Share
(2.34)
Revenue Per Share
24.174
Quarterly Revenue Growth
0.009
Return On Assets
0.0467
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.